White matter alterations in deficit schizophrenia

Neuropsychopharmacology

Volumn 34, Issue 6, 2009, Pages 1514-1522

  Rowland, Laura M ^a,d   Spieker, Elena A ^a   Francis, Alan ^a   Barker, Peter B ^b,c   Carpenter, William T ^a   Buchanan, Robert W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KENNEDY KRIEGER INSTITUTE   (United States)

^d MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Deficit schizophrenia; DTI; Fiber tracking; MRS; SLF

Indexed keywords

CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ANATOMICAL VARIATION; ANISOTROPY; ARTICLE; BRAIN CORTEX; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; MALE; NEUROCHEMISTRY; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RIGHT HEMISPHERE; SCHIZOPHRENIA; WHITE MATTER;

ADULT; ANALYSIS OF VARIANCE; ANISOTROPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NERVE FIBERS, MYELINATED; NEURAL PATHWAYS; ORGAN SIZE; PARIETAL LOBE; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 64949185316     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.207     Document Type: Article

References (52)

1. Andreasen NC (1984). The Scale for the Assessment of Negative Symptoms. University of Iowa: Iowa City.
2. Artiges E, Martinot JL, Verdys M, Attar-Levy D, Mazoyer B, Tzourio N et al (2000). Altered hemispheric functional dominance during word generation in negative schizophrenia. Schizophr Bull 26: 709-721.
3. Blake ML (2003). Affective language and humor appreciation after right hemisphere brain damage. Semin Speech Lang 24: 107-119.
4. Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F et al (1993). Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 150: 59-65.
5. Buchanan RW, Francis A, Arango C, Miller K, Lefkowitz DM, McMahon RP et al (2004). Morphometric assessment of the heteromodal association cortex in schizophrenia. Am J Psychiatry 161: 322-331.
6. Buchanan RW, Vladar K, Barta RE, Pearlson GD (1998). Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry 155: 1049-1055.
7. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA et al (1998). MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9: 425-430.
8. Carpenter Jr WT, Heinrichs DW, Alphs LD (1985). Treatment of negative symptoms. Schizophr Bull 11: 440-452.
9. Carpenter Jr WT, Heinrichs DW, Wagman AM (1988). Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145: 578-583.
10. Delamillieure P, Fernandez J, Constans JM, Brazo P, Benali K, Abadie P et al (2000). Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report. Am J Psychiatry 157: 641-643.
11. Farrell JA, Landman BA, Jones CK, Smith SA, Prince JL, van Zijl PC et al (2007). Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging 26: 756-767.
12. First MB, Spitzer RL, Gibbon M, Williams JBW (1995). Structured Clinical Interview for DSM-IV Axis I Disorders, Non-Patient Edition (SCID-NP), version 2. New York State Psychiatric Institute, Biometrics Research: New York.
13. Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA (2000). Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 68: 242-244.
14. Galderisi S, Quarantelli M, Volpe U, Mucci A, Cassano GB, Invernizzi G et al (2008). Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr Bull 34: 393-401.
15. Gold JM, Queern C, Iannone VN, Buchanan RW (1999). Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am J Psychiatry 156: 1944-1950.
16. Gonul AS, Kula M, eg;el E, u A, Sofuoglu S (2003). A Tc-99m HMPAO SPECT study of regional cerebral blood flow in drug-free schizophrenic patients with deficit and non-deficit syndrome. Psychiatry Res 123: 199-205.
17. Gur RE, Mozley PD, Shtasel DL, Cannon TD, Gallacher F, Turetsky B et al (1994). Clinical subtypes of schizophrenia: differences in brain and CSF volume. Am J Psychiatry 151: 343-350.
18. Heckers S, Goff D, Schacter DL, Savage CR, Fischman AJ, Alpert NM et al (1999). Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Arch Gen Psychiatry 56: 1117-1123.
19. Hof PR, Haroutunian V, Friedrich Jr VL, Byne W, Buitron C, Perl DP et al (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53: 1075-1085.
20. Jenkinson M, Smith S (2001). A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143-156.
21. Jiang H, van Zijl PC, Kim J, Pearlson GD, Mori S (2006). DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 81: 106-116.
22. Jones DK, Catani M, Pierpaoli C, Reeves SJ, Shergill SS, O'Sullivan M et al (2006). Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp 27: 230-238.
23. Kirkpatrick B, Amador XF, Flaum M, Yale SA, Gorman JM, Carpenter Jr WT et al (1996). The deficit syndrome in the DSM-IV field trial: I. Alcohol and other drug abuse. Schizophr Res 20: 69-77.
24. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter Jr WT (1989). The Schedule for the Deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30: 119-123.
25. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter Jr WT (2001). A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58: 165-171.
26. Kirkpatrick B, Conley RC, Kakoyannis A, Reep RL, Roberts RC (1999). Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: an unbiased cell-counting study. Synapse 34: 95-102.
27. Kirkpatrick B, Messias NC, Conley RR, Roberts RC (2003). Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J Nerv Ment Dis 191: 563-567.
28. Kubicki M, McCarley R, Westin CF, Park HJ, Maier S, Kikinis R et al (2007). A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res 41: 15-30.
29. Kucharska-Pietura K (2006). Disordered emotional processing in schizophrenia and one-sided brain damage. Prog Brain Res 156: 467-479.
30. Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter Jr WT (2001). Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatry 158: 1797-1808.
31. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A (1999). Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56: 367-374.
32. Merrin EL, Floyd TC (1996). Negative symptoms and EEG alpha in schizophrenia: a replication. Schizophr Res 19: 151-161.
33. Mitchell RL, Crow TJ (2005). Right hemisphere language functions and schizophrenia: the forgotten hemisphere. Brain 128: 963-978.
34. Mori S, Wakana S, Nagae-Poetscher LM, van Zil PCM (2005). MRI Atlas of Human White Matter. Elsevier B.V.: Amsterdam, The Netherlands.
35. Overall JF, Gorham DR (1962). The brief psychiatric rating scale. Psychol Rep 10: 799-812.
36. Pell MD (2006). Judging emotion and attitudes from prosody following brain damage. Prog Brain Res 156: 303-317.
37. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D et al (2002). A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry 159: 227-237.
38. Provencher SW (2001). Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14: 260-264.
39. Randolph C (1988). RBANS Manual - FRepeatable Battery for the Assessment of Neuropsychological Status. Tex, Psychological Corp (Harcourt): San Antonio.
40. Shin YW, Kwon JS, Ha TH, Park HJ, Kim DJ, Hong SB et al (2006). Increased water diffusivity in the frontal and temporal cortices of schizophrenic patients. Neuroimage 30: 1285-1291.
41. Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K et al (2003). Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 64: 63-71.
42. Sigmundsson T, Suckling J, Maier M, Williams S, Bullmore E, Greenwood K et al (2001). Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 158: 234-243.
43. Skelly LR, Calhoun V, Meda SA, Kim J, Mathalon DH, Pearlson GD (2008). Diffusion tensor imaging in schizophrenia: relationship to symptoms. Schizophr Res 98: 157-162.
44. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN et al (1992). Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluor-odeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49: 522-530.
45. Thoma RJ, Hanlon FM, Moses SN, Ricker D, Huang M, Edgar C et al (2005). M50 sensory gating predicts negative symptoms in schizophrenia. Schizophr Res 73: 311-318.
46. Uranova NA, Orlovskaya DD (1996). Ultrastructural pathology of neuronal connectivity in postmortem brains of schizophrenic patients, in Annals of Psychiatry: Basic and Clinical Neuro-sciences, vol 6. Edited by Cacabelos R. Barcelona, Prous. Science, pp 56-72.
47. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V et al (2001). Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55: 597-610.
48. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67: 269-275.
49. Uranova NA, Vostrikov VM, Vikhreva OV, Zimina IS, Kolomeets NS, Orlovskaya DD (2007). The role of oligodendrocyte pathology in schizophrenia. Int J Neuropsychopharmacol 10: 537-545.
50. Vostrikov VM, Uranova NA, Orlovskaya DD (2007). Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res 94: 273-280.
51. Wakana S, Jiang H, Nagae-Poetscher LM, van Zijl PC, Mori S (2004). Fiber tract-based atlas of human white matter anatomy. Radiology 230: 77-87.
52. Wolkin A, Choi SJ, Szilagyi S, Sanfilipo M, Rotrosen JP, Lim KO (2003). Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. Am J Psychiatry 160: 572-574.